CVR 34896828Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København ØFounded 27 Dec 2012
Employees
4
CVR registry, Dec 2025
0 (0%) over 12 months
Result
-4.5M
DKK, annual report 2025
Equity
-10.8M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about AVILEX PHARMA ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexNovo Holdings A/SCVR 24257630, 50% to under 66.7% of capital and votes, since 30 Apr 2015
KRISTIAN STRØMGAARD HOLDING ApSCVR 34896720, 20% to under 25% of capital and votes, since 27 Dec 2012
and 2 moreKristian Strømgaardsince 31 Dec 2013
Equity was negative at 31 Dec 2025: -10.8M DKK. Dandex estimate, computed 31 Oct 2026.
CVR 2425763050% to under 66.7% of capital and votessince 30 Apr 2015
CVR 305102755% to under 10% of capital and votessince 11 Jan 2019
CVR 3489672020% to under 25% of capital and votessince 27 Dec 2012
CVR 3669444010% to under 15% of capital and votessince 3 Mar 2015
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
5% to under 10% of capital and votes21 Dec 2018 to 11 Jan 2019
10% to under 15% of capital and votes21 Dec 2018 to 11 Jan 2019
Ultimate controller
CVR 10582989Commercial foundation (Erhvervsdrivende fond)
Holds 100% of capital and votes in Novo Holdings A/S, since 16 Oct 1999
Holding company
CVR 24257630Public limited company (A/S)
Holds 50% to under 66.7% of capital and votes in AVILEX PHARMA ApS, since 30 Apr 2015
This company
AVILEX PHARMA ApS
CVR 34896828
CVR records founders at incorporation. It does not record whether they are alive or still involved.
27 Dec 2012 to 31 Oct 2026.
27 Dec 2012 to 31 Oct 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Not reported | 45,479 | 0 | Not reported | Not reported |
| Operating profit | -8,684 | +34,858 | -6,034 | -4,803 | -4,240 |
| Result for the year | -6,611 | +28,600 | -6,756 | -4,428 | -4,530 |
| Equity | -25,260 | 4,917 | -1,839 | -6,267 | -10,797 |
| Total assets | 4,917 | 31,591 | 27,875 | 21,559 | 18,391 |
| Employees (average) | 2 | 2 | 2 | 2 | 2 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | Not reported | n.m.note 1 | -100% | Not reported | Not reported |
| EBIT margin (overskudsgrad) | Not reported | 76.6% | n.m.note 2 | Not reported | Not reported |
| Employee growth (vækst i antal ansatte) | -50% | 0% | 0% | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 26,801 | -9,840 | -2,533 | 7,275 | 12,045 |
| ROIC (afkast af investeret kapital) | -1,357.4%note 3 | n.m.note 4 | n.m.note 4 | -479.1%note 3 | -293.2%note 3 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 21 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 25 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 3 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 5 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 2 May 2022
AVILEX PHARMA ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 1 Dec 2026.
AVILEX PHARMA ApS has moved to a new address, with a potential need for new suppliers.
Signal, a Dandex estimate. Lapses 1 Nov 2026.
1 registered in CVR.
P-number 1018162918Jagtvej 162, 2100 København Ø
No other current company drawn.
